Trial Profile
Efficacy and adverse events in 2 different SLIT tablets for house dust mite allergy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Oct 2018
Price :
$35
*
At a glance
- Drugs House dust mite allergy immunotherapy-ALK Abello (Primary) ; S 524101 (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- 11 Oct 2018 Status changed to discontinued.
- 04 Apr 2017 New trial record